Mirum Pharmaceuticals raises $120m to advance Maralixibat for rare liver diseases

Mirum Pharmaceuticals, a clinical-stage pharmaceutical company, has successfully raised $120 million in a Series A funding round to propel the development of its lead drug, ... Read More